Connection

STEPHEN YENZEN LAI to Apoptosis

This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Apoptosis.
Connection Strength

0.164
  1. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4652-e4665.
    View in: PubMed
    Score: 0.071
  2. Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 2012 Dec; 48(12):1220-6.
    View in: PubMed
    Score: 0.037
  3. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
    View in: PubMed
    Score: 0.034
  4. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem. 1998 Apr 10; 273(15):9255-60.
    View in: PubMed
    Score: 0.014
  5. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2010 Jul; 9(7):1968-76.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.